| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A BCB4 variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndrome
|
Biyoukar, Moustafa
|
|
|
|
11 |
p.
|
article
|
| 2 |
Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease
|
Balcar, Lorenz
|
|
|
|
11 |
p.
|
article
|
| 3 |
Ammonia rises from the ashes!
|
Weiss, Nicolas
|
|
|
|
11 |
p.
|
article
|
| 4 |
Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV
|
Mateo, Roberto
|
|
|
|
11 |
p.
|
article
|
| 5 |
Categorization of differing types of non-tumoral portal vein thrombosis based on the location and hemodynamic changes during liver transplantation
|
Yang, Zhe
|
|
|
|
11 |
p.
|
article
|
| 6 |
Circadian control of ConA-induced acute liver injury and inflammatory response via Bmal1 regulation of Junb
|
Liu, Zhaiyi
|
|
|
|
11 |
p.
|
article
|
| 7 |
Circulating neutrophil anti-pathogen dysfunction in cirrhosis
|
Balazs, Irina
|
|
|
|
11 |
p.
|
article
|
| 8 |
Cirrhosis-related sarcopenia may not resolve after liver transplantation
|
Brown, Sara
|
|
|
|
11 |
p.
|
article
|
| 9 |
Contents
|
|
|
|
|
11 |
p.
|
article
|
| 10 |
Contents
|
|
|
|
|
11 |
p.
|
article
|
| 11 |
Copyright and information
|
|
|
|
|
11 |
p.
|
article
|
| 12 |
Copyright and information
|
|
|
|
|
11 |
p.
|
article
|
| 13 |
Distribution of non-ceruloplasmin-bound copper after i.v. 64Cu injection studied with PET/CT in patients with Wilson disease
|
Munk, Ditte Emilie
|
|
|
|
11 |
p.
|
article
|
| 14 |
Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?
|
Zhou, Yi-Hua
|
|
|
|
11 |
p.
|
article
|
| 15 |
Editorial Board page
|
|
|
|
|
11 |
p.
|
article
|
| 16 |
Editorial Board page
|
|
|
|
|
11 |
p.
|
article
|
| 17 |
Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis
|
Schramm, Christoph
|
|
|
|
11 |
p.
|
article
|
| 18 |
HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV
|
Cargill, Tamsin
|
|
|
|
11 |
p.
|
article
|
| 19 |
Hepatic venous pressure gradient in sinusoidal obstruction syndrome: Diagnostic value and link with histological lesions
|
Gressens, Simon B.
|
|
|
|
11 |
p.
|
article
|
| 20 |
Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinoma
|
de Beijer, Monique T.A.
|
|
|
|
11 |
p.
|
article
|
| 21 |
Impact of the COVID-19 pandemic on the care and outcomes of people with NAFLD-related cirrhosis
|
Rivera-Esteban, Jesús
|
|
|
|
11 |
p.
|
article
|
| 22 |
Intestinal Pgc1α ablation protects from liver steatosis and fibrosis
|
Piccinin, Elena
|
|
|
|
11 |
p.
|
article
|
| 23 |
JNKs protect from cholestatic liver disease progression by modulating Apelin signalling
|
Mohamed, Mohamed Ramadan
|
|
|
|
11 |
p.
|
article
|
| 24 |
Macrophage RIPK3 triggers inflammation and cell death via the XBP1–Foxo1 axis in liver ischaemia–reperfusion injury
|
Qu, Xiaoye
|
|
|
|
11 |
p.
|
article
|
| 25 |
Management of liver disease and portal hypertension in common variable immunodeficiency (CVID)
|
Baumert, Lukas S.
|
|
|
|
11 |
p.
|
article
|
| 26 |
Mechanobiology of portal hypertension
|
Felli, Eric
|
|
|
|
11 |
p.
|
article
|
| 27 |
Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysis
|
Sierks, Dana
|
|
|
|
11 |
p.
|
article
|
| 28 |
Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2 -/- mouse model of sclerosing cholangitis
|
Fuchs, Claudia D.
|
|
|
|
11 |
p.
|
article
|
| 29 |
24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγ
|
Grander, Christoph
|
|
|
|
11 |
p.
|
article
|
| 30 |
Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis
|
Cazzagon, Nora
|
|
|
|
11 |
p.
|
article
|
| 31 |
Reply to: “Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?”
|
Matthews, Philippa C.
|
|
|
|
11 |
p.
|
article
|
| 32 |
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis
|
Overi, Diletta
|
|
|
|
11 |
p.
|
article
|
| 33 |
Sex differences in chronic liver disease and benign liver lesions
|
Cooper, Katherine M.
|
|
|
|
11 |
p.
|
article
|
| 34 |
Single-cell landscape of immune cells in human livers affected by HBV-related cirrhosis
|
Bai, Qingquan
|
|
|
|
11 |
p.
|
article
|
| 35 |
Single cell RNA-sequencing analysis reveals that N-acetylcysteine partially reverses hepatic immune dysfunction in biliary atresia
|
Ye, Rongchen
|
|
|
|
11 |
p.
|
article
|
| 36 |
Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case–control study
|
Deltenre, Pierre
|
|
|
|
11 |
p.
|
article
|
| 37 |
Spleen volume-based non-invasive tool for predicting hepatic decompensation in people with compensated cirrhosis (CHESS1701)
|
Yu, Qian
|
|
|
|
11 |
p.
|
article
|
| 38 |
Steatosis drives monocyte-derived macrophage accumulation in human metabolic dysfunction-associated fatty liver disease
|
Chan, Mandy M.
|
|
|
|
11 |
p.
|
article
|
| 39 |
Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis
|
Braadland, Peder Rustøen
|
|
|
|
11 |
p.
|
article
|
| 40 |
Survey uncovering variations in the management of primary sclerosing cholangitis across Europe
|
Eliasson, Johanna
|
|
|
|
11 |
p.
|
article
|
| 41 |
Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice
|
Kunst, Roni F.
|
|
|
|
11 |
p.
|
article
|
| 42 |
The novel cyclophilin inhibitor C105SR reduces hepatic ischaemia–reperfusion injury via mitoprotection
|
Kheyar, Amel
|
|
|
|
11 |
p.
|
article
|
| 43 |
The role of ischaemia-reperfusion injury and liver regeneration in hepatic tumour recurrence
|
Maspero, Marianna
|
|
|
|
11 |
p.
|
article
|
| 44 |
Traditional lifestyle factors partly mediate the association of socioeconomic position with intrahepatic lipid content: The Maastricht study
|
Ren, Zhewen
|
|
|
|
11 |
p.
|
article
|
| 45 |
Trends in hepatocellular carcinoma stage by racial/ethnic group in the United States, 1992–2019
|
Alvarez, Christian S.
|
|
|
|
11 |
p.
|
article
|
| 46 |
Utility of ElastPQ point-shear wave elastography in the work-up of patients with primary sclerosing cholangitis
|
Roccarina, Davide
|
|
|
|
11 |
p.
|
article
|
| 47 |
Waiting time dictates impact of frailty: A Spanish multicenter prospective study
|
Puchades, Lorena
|
|
|
|
11 |
p.
|
article
|
| 48 |
XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression
|
Wang, Qi
|
|
|
|
11 |
p.
|
article
|
Journal description